CSIMarket
 

Hyperfine Inc   (HYPR)
Other Ticker:  
 

Hyperfine Inc 's Working Capital Per Sales

HYPR's Working Capital and Revenue growth



HYPR Working Capital Per Revenue (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Working Capital Change -31.43 % -31.92 % -32.76 % -37.98 % -
Y / Y Revenue Change -9.54 % 59.43 % 74.62 % -4.81 % -
Working Capital Per Revenue 12.14 12.99 15.96 20.55 23
Total Ranking # 3038 # 2669 # 2294 # 2542 # 2054
Seq. Working Capital Change -9.8 % -8.57 % -8.95 % -8.68 % -10.45 %
Seq. Revenue Change -13.09 % -7.25 % 85.04 % -39.35 % 53.16 %





Comment on HYPR's Working Capital Per Revenue in the third quarter 2023
Hyperfine Inc 's Working Capital Per Revenue in the Q3 2023 sequentially fell to 12.14 a new company low. Due to decrease of revenue year on year in the third quarter 2023 by -9.54%.

Within Healthcare sector 126 other companies have achieved lower Working Capital Per Revenue during the Q3 2023. While Working Capital Per Revenue total ranking has deteriorated in the third quarter 2023, compared to previous quarter from 2669 to 3038.
Working Capital Per Revenue Ranking
Within: No.
Industry # 26
Sector # 127
S&P 500 # 3038


Working Capital Per Revenue Statistics
High Average Low
22.58
16.84
12.14
(Sep 30 2022)   (Sep 30 2023)



Financial Statements
Hyperfine Inc 's Working Capital $ 90 Millions Visit HYPR's Balance sheet
Hyperfine Inc 's Revenues $ 2 Millions Visit HYPR's Income Statement
Where are HYPR's Sales coming from? Visit HYPR's Sales by Geography




Companies with similar Average Working Capital Per Revenue for 12 months ending Sep 30 2023, within Healthcare Sector Working Capital Per Revenue
Lumos Pharma Inc   30.84 
Cardiff Oncology inc   29.95 
Agios Pharmaceuticals Inc   29.80 
Enzon Pharmaceuticals inc   27.93 
Anaptysbio Inc   26.88 
Bioaffinity Technologies Inc   24.93 
Stoke Therapeutics Inc   23.81 
Seer Inc   22.23 
Mirati Therapeutics Inc   21.88 
Catheter Precision Inc   21.63 
Ambrx Biopharma Inc   19.17 
Absci Corp  18.88 
Inovio Pharmaceuticals Inc   18.76 
Senti Biosciences Inc   18.41 
Verrica Pharmaceuticals Inc   17.75 
Intellia Therapeutics Inc   17.35 
Ideaya Biosciences Inc   16.89 
Bolt Biotherapeutics Inc   16.84 
Abcellera Biologics Inc   16.77 
Co diagnostics Inc   16.62 
Miromatrix Medical inc   16.11 
Syros Pharmaceuticals Inc   15.61 
Clearside Biomedical Inc   15.49 
Bicycle Therapeutics Plc  15.24 
Vir Biotechnology Inc   15.16 
Vaxart Inc   14.73 
Cue Biopharma Inc   13.45 
Roivant Sciences Ltd   13.40 
Editas Medicine Inc   12.70 
Tff Pharmaceuticals Inc   12.43 
Date modified: 2023-11-12T11:42:03+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com